Cetera Advisors LLC Haleon PLC Transaction History

Cetera Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$8.02 - $8.67 $552,233 - $596,990	68,857 Added 524.27%	81,991 $696,000
Q4 2023 Feb 13, 2024	SELL	$7.78 - $8.62 $32,629 - $36,152	-4,194 Reduced 24.2%	13,134 $108,000
Q3 2023 Nov 14, 2023	BUY	$7.85 - $8.94 $13,431 - $15,296	1,711 Added 10.96%	17,328 $144,000
Q2 2023 Aug 09, 2023	SELL	$8.04 - $9.0 $59,528 - $66,636	-7,404 Reduced 32.16%	15,617 $130,000
Q1 2023 May 15, 2023	SELL	$7.57 - $8.37 $9,242 - $10,219	-1,221 Reduced 5.04%	23,021 $187,000
Q4 2022 Feb 14, 2023	SELL	$5.96 - $8.06 $338,468 - $457,727	-56,790 Reduced 70.08%	24,242 $193,000
Q3 2022 Nov 10, 2022	BUY	$5.63 - $7.5 $456,210 - $607,740	81,032 New	81,032 $493,000

639

412M

149K

16K

Ticker HLN
Exchange
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 4,617,290,240
Market Cap $44.8B
Description
Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...

Get notified when there are updates to the investment portfolio of Cetera Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Cetera Advisors LLC with notifications on news.